Financial News
Fate Therapeutics (NQ: FATE )
4.445
+0.175
(+4.10%)
Streaming Delayed Price
Updated: 2:03 PM EDT, Jul 22, 2024
Add to My Watchlist
All News about Fate Therapeutics
![](https://cdn.benzinga.com/files/images/story/2023/02/13/image31_0.jpeg?width=1200&height=800&fit=crop)
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
![](https://ml.globenewswire.com/media/29481954-f2ff-4756-b5a9-d982a6497bd0/small/bes-mark-jpg.jpg)
Analyst Ratings for Fate Therapeutics
January 24, 2023
Via Benzinga
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
![](https://ml.globenewswire.com/media/29481954-f2ff-4756-b5a9-d982a6497bd0/small/bes-mark-jpg.jpg)
![](https://mms.businesswire.com/media/20230202005891/en/805463/22/business_Wire_Robbins_LLP.jpg)
![](https://mms.businesswire.com/media/20230201006122/en/774509/22/new_KM_logo.jpg)
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
Via NewMediaWire
Topics
Lawsuit
![](https://mms.businesswire.com/media/20230127005395/en/1138077/5/RGRD_Logo_BusinessWire.jpg)
![](https://ml.globenewswire.com/media/29481954-f2ff-4756-b5a9-d982a6497bd0/small/bes-mark-jpg.jpg)
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
Via NewMediaWire
Topics
Lawsuit
![](https://cdn.benzinga.com/files/images/story/2023/01/27/image10.jpg?width=1200&height=800&fit=crop)
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
Via NewMediaWire
Topics
Lawsuit
![](https://mms.businesswire.com/media/20230126005345/en/478343/5/GPM_Logo_Colo.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://mms.businesswire.com/media/20230124006120/en/1138077/5/RGRD_Logo_BusinessWire.jpg)
![](https://www.marketbeat.com/logos/articles/small_stock-image_180756848_S.jpg)
![](https://mms.businesswire.com/media/20230124005972/en/805463/22/business_Wire_Robbins_LLP.jpg)
![](https://mms.businesswire.com/media/20230124005457/en/765953/22/Close_Up_Logo_HD_Blue.jpg)
![](https://mms.businesswire.com/media/20230124005153/en/779279/5/Screen_Shot_2020-03-10_at_10.22.21_AM.jpg)
Benzinga's Top Ratings Upgrades, Downgrades For January 24, 2023
January 24, 2023
Via Benzinga
![](https://mms.businesswire.com/media/20230124005466/en/827144/22/Schall-Firm-Logo-640x360.jpg)
![](https://mms.businesswire.com/media/20230123005202/en/538768/22/BES_Mark.jpg)
![](https://mms.businesswire.com/media/20230123005808/en/478343/5/GPM_Logo_Colo.jpg)
![](https://mms.businesswire.com/media/20230123005787/en/774509/22/new_KM_logo.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://ml.globenewswire.com/media/38c8d81f-4a6b-4f23-8411-e6be6a60dda1/small/ld-logo-png.png)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.